University of Minnesota Cancer Center Researchers Present at American Society of Hematology Meeting
CCRF supported researchers share their findings at ASH.
Several Children's Cancer Research Fund researchers and doctors are among the presenters at the American Society of Hematology (ASH) meeting in Atlanta, December 8-12, 2007. Donations to Children's Cancer Research Fund helps make pioneering research, such as the studies highlighted below, possible.
Those giving oral presentations include:
Jakub Tolar, M.D., Ph.D., Assistant Professor, Pediatric Hematology/Oncology/Bone Marrow Transplantation - "Induction of skin repair mechanism by bone marrow derived SLAM family receptor enriched cells in murine epidermolysis bullosa" and "Glycosaminoglycans as anticoagulants in mucopolysaccharidosis Type I (MPS I)"
Michael Verneris, M.D., Assistant Professor, Pediatric Hematology/Oncology/Bone Marrow Transplantation - "Umbilical cord blood T cells express the natural cytotoxicity receptors, NKp30, NKp44 and Nkp46 after IL-15 stimulation, but only NKp30 is functional"
Those providing poster presentations include:
K. Scott Baker, M.D., Associate Professor, Pediatric Hematology/Oncology/Bone Marrow Transplantation - "Clinical results: Alternative donor transplantation-matched unrelated donors and haploidentical transplants"
Wei Chen, M.D., Ph.D., Associate Professor, Pediatric Bone Marrow Transplantation - "The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation"
Ashish Kumar, M.D., Ph.D., Assistant Professor, Pediatric Hematology/Oncology/Bone Marrow Transplantation - "MEIS1 Is a Promising New Target for Leukemia Therapy"
Cary Martinez, M.D., Pediatric Bone Marrow Transplantation Fellow - "GD2+ selected mesenchymal stromal cells demonstrate a more robust proliferation and differentiation potential compared to unselected cells"
Angie Smith, M.D., Fellow, Pediatric Bone Marrow Transplantation - "Reversible bony changes after treatment with bevacizumab in a child with cutaneovisceral angiomatosis with thrombocytopenia syndrome: A case report and review of the literature"
Jakub Tolar, M.D., Ph.D., Assistant Professor, Pediatric Hematology/Oncology/Bone Marrow Transplantation - "Dyskeratosis congenita: Low regimen-related toxicity following hematopoietic cell transplantation using a reduced intensity conditioning regimen" and "Glycosaminoglycans as anticoagulants in mucopolysaccharidosis Type I (MPS I)" and "Brain sparing conditioning regimen and umbilical cord blood transplantation for inherited high risk neurologic metabolic diseases"